Tumor risk via p53 pathway interference Mitigate risk by: Careful patient selection: exclude patients with pre-existing active malignancy or high tumour risk (e.g., known p53 mutations, familial cancer syndromes)
Reach out now with a plan: confirm their current prescription status, discuss alternative formulations (gels, creams, oral options), and establish a compounding pharmacy relationship as a backup if their preferred product remains unavailable
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val 15 aa Source: Synthetic fragment of human gastric juice protein BPC Research areas: Tissue repair, angiogenesis, soft tissue healing Verification: HPLC + electrospray mass spectrometry Documentation: COA with chromatogram included Contents: One vial containing 10mg BPC-157 as lyophilized powder
That BPC 157, originally found in a longer form in stomach juices, was recently banned for being a non-approved substance, while the growth hormone secretagogues also feature on WADAs prohibited list under peptide hormones, growth factors, related substances, and mimetics. It can be challenging for laboratories to detect this type of doping, though
